Biliczki Péter, Acsai Károly, Virág László, Tálosi László, Jost Norbert, Biliczki András, Papp Julius Gy, Varró András
Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Eur J Pharmacol. 2005 Mar 14;510(3):161-6. doi: 10.1016/j.ejphar.2004.12.040.
The cellular mechanism of action of terikalant, an investigational antiarrhythmic agent known to block the inward rectifier and other potassium currents, has not yet been fully clarified. The aim of the present study was therefore to analyse the in vitro electrophysiological effects of terikalant in canine isolated ventricular muscle and Purkinje fibers by applying the standard microelectrode technique. The effects of terikalant on the duration of action potential at a stimulation cycle length of 1000 ms and on the maximum upstroke velocity of the action potential in right ventricular papillary muscle were examined at 1, 2.5, 10, and 20 microM concentrations. Terikalant significantly prolonged the action potential duration measured both at 50% and 90% of repolarization in concentration-dependent manner. The maximum upstroke velocity of the action potential was unaffected at 1 and 2.5 microM concentrations. However, this parameter was significantly reduced at 10 and 20 microM concentrations of terikalant. In Purkinje fibers terikalant (2.5 microM) also produced a marked action potential lengthening effect. Frequency dependence (cycle length of 300-5000 ms) of the action potential lengthening effect of terikalant was studied at a concentration of 2.5 microM. Prolongation of the duration of action potential occurred in a reverse frequency-dependent manner both in papillary muscle and Purkinje fibers, with a more pronounced frequency-dependence observed in Purkinje fibers. The onset kinetics of the terikalant (10 microM) induced block of the maximum upstroke velocity of the action potential was rapid (0.6+/-0.1 beat(-1), n=6) like that of Class I/B antiarrhythmics, and the offset (recovery) kinetics of the drug (2956+/-696 ms, n=6) best resembled that of Class I/A antiarrhythmic drugs. It was concluded that terikalant, unlike pure Class III antiarrhythmic drugs, has combined mode of action by lengthening repolarization and blocking the inward sodium current in a use-dependent manner.
特立卡兰特是一种已知可阻断内向整流钾电流和其他钾电流的研究性抗心律失常药物,其细胞作用机制尚未完全阐明。因此,本研究的目的是通过应用标准微电极技术,分析特立卡兰特对犬离体心室肌和浦肯野纤维的体外电生理效应。在1、2.5、10和20微摩尔浓度下,研究了特立卡兰特对刺激周期长度为1000毫秒时动作电位持续时间以及右心室乳头肌动作电位最大上升速度的影响。特立卡兰特以浓度依赖性方式显著延长了复极化50%和90%时测得的动作电位持续时间。在1和2.5微摩尔浓度下,动作电位最大上升速度未受影响。然而,在特立卡兰特浓度为10和20微摩尔时,该参数显著降低。在浦肯野纤维中,特立卡兰特(2.5微摩尔)也产生了明显的动作电位延长效应。在2.5微摩尔浓度下研究了特立卡兰特动作电位延长效应的频率依赖性(周期长度为300 - 5000毫秒)。动作电位持续时间的延长在乳头肌和浦肯野纤维中均以反向频率依赖性方式发生,在浦肯野纤维中观察到更明显的频率依赖性。特立卡兰特(10微摩尔)诱导动作电位最大上升速度阻滞的起始动力学很快(0.6±0.1次/搏(-1),n = 6),类似于I/B类抗心律失常药物,而药物的消除(恢复)动力学(2956±696毫秒,n = 6)最类似于I/A类抗心律失常药物。得出的结论是,与纯III类抗心律失常药物不同,特立卡兰特具有通过延长复极化和以使用依赖性方式阻断内向钠电流的联合作用模式。